VBI VACCINES INC CDA - COM NEW (VBIVQ)

CUSIP: 91822J202

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class
Equity / COM NEW
Total 13F shares
2,144,382
Share change
+1,964,476
Total reported value
$7,053,668
Price per share
$3.29
Number of holders
42
Value change
+$6,998,668
Number of buys
42
Number of sells
1

Quarterly Holders Quick Answers

What is CUSIP 91822J202?
CUSIP 91822J202 identifies VBIVQ - VBI VACCINES INC CDA - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of VBI VACCINES INC CDA - COM NEW (VBIVQ) as of Q2 2023

As of 30 Jun 2023, VBI VACCINES INC CDA - COM NEW (VBIVQ) was held by 42 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,144,382 shares. The largest 10 holders included PERCEPTIVE ADVISORS LLC, BlackRock Inc., Cambridge Investment Research Advisors, Inc., MILLENNIUM MANAGEMENT LLC, MORGAN STANLEY, GEODE CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, GENERAL AMERICAN INVESTORS CO INC, Y-Intercept (Hong Kong) Ltd, and STATE STREET CORP. This page lists 42 institutional shareholders reporting positions in this security for the Q2 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.